Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation

被引：9

作者：

Halperin, Jonathan L. ^{[1
]}

Dorian, Paul ^{[2
]}

机构：

[1] Mt Sinai Med Ctr, Cardiovasc Inst, 5th Ave 100th St, New York, NY 10029 USA

[2] Univ Toronto, St Michaels Hosp, Div Cardiol, Toronto, ON, Canada

来源：

CURRENT CARDIOLOGY REVIEWS | 2014年 / 10卷 / 04期

关键词：

Anticoagulation; antithrombotic therapy; atrial fibrillation; factor IIa inhibitors; factor Xa inhibitors; stroke; thrombin; thromboembolism;

D O I：

10.2174/1573403X10666140513104523

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with non-valvular atrial fibrillation (AF) face an increased risk of stroke compared with those in normal sinus rhythm. The vitamin K antagonist warfarin, available for over half a century, is highly effective in reducing the risk of stroke in patients with AF, but it is a difficult drug to use properly. As a result, it is challenging to keep the anticoagulant effect of warfarin in the desired range. Newer oral anticoagulants (NOACs) that directly inhibit Factor IIa (thrombin) or Factor Xa provide reliable anticoagulation when administer in fixed oral doses without routine coagulation monitoring. This manuscript will review in detail the pivotal trials of these NOACs that led to their approval as well as comment on the factors that should influence their selection.

引用

页码：297 / 302

页数：6

共 33 条

[1] Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial [J].

Alexander, John H. ;

Becker, Richard C. ;

Bhatt, Deepak L. ;

Cools, Frank ;

Crea, Filippo ;

Dellborg, Mikael ;

Fox, Keith A. A. ;

Goodman, Shaun G. ;

Harrington, Robert A. ;

Huber, Kurt ;

Husted, Steen ;

Lewis, Basil S. ;

Lopez-Sendon, Jose ;

Mohan, Puneet ;

Montalescot, Gilles ;

Ruda, Mikhail ;

Ruzyllo, Witold ;

Verheugt, Freek ;

Wallentin, Lars ;

Darius, Harald ;

Simoons, Maarten ;

Boersma, Eric ;

DeLemos, James ;

Spencer, Fred .

CIRCULATION, 2009, 119 (22) :2877-U39

[2] Apixaban in Patients with Atrial Fibrillation [J].

Connolly, Stuart J. ;

Eikelboom, John ;

Joyner, Campbell ;

Diener, Hans-Christoph ;

Hart, Robert ;

Golitsyn, Sergey ;

Flaker, Greg ;

Avezum, Alvaro ;

Hohnloser, Stefan H. ;

Diaz, Rafael ;

Talajic, Mario ;

Zhu, Jun ;

Pais, Prem ;

Budaj, Andrzej ;

Parkhomenko, Alexander ;

Jansky, Petr ;

Commerford, Patrick ;

Tan, Ru San ;

Sim, Kui-Hian ;

Lewis, Basil S. ;

Van Mieghem, Walter ;

Lip, Gregory Y. H. ;

Kim, Jae Hyung ;

Lanas-Zanetti, Fernando ;

Gonzalez-Hermosillo, Antonio ;

Dans, Antonio L. ;

Munawar, Muhammad ;

O'Donnell, Martin ;

Lawrence, John ;

Lewis, Gayle ;

Afzal, Rizwan ;

Yusuf, Salim .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09) :806-817

[3] Newly Identified Events in the RE-LY Trial [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Reilly, Paul A. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) :1875-1876

[4]

Connolly SJ, 2009, NEW ENGL J MED, V361, P2674

[5]

Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X

[6] Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation - Pooled analysis from the SPORTIF III and V studies [J].

Diener, HC .

CEREBROVASCULAR DISEASES, 2006, 21 (04) :279-293

[7] Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial [J].

Easton, J. Donald ;

Lopes, Renato D. ;

Bahit, M. Cecilia ;

Wojdyla, Daniel M. ;

Granger, Christopher B. ;

Wallentin, Lars ;

Alings, Marco ;

Goto, Shinya ;

Lewis, Basil S. ;

Rosenqvist, Marten ;

Hanna, Michael ;

Mohan, Puneet ;

Alexander, John H. ;

Diener, Hans-Christoph .

LANCET NEUROLOGY, 2012, 11 (06) :503-511

[8] Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial [J].

Eikelboom, John W. ;

Wallentin, Lars ;

Connolly, Stuart J. ;

Ezekowitz, Mike ;

Healey, Jeff S. ;

Oldgren, Jonas ;

Yang, Sean ;

Alings, Marco ;

Kaatz, Scott ;

Hohnloser, Stefan H. ;

Diener, Hans-Christoph ;

Franzosi, Maria Grazia ;

Huber, Kurt ;

Reilly, Paul ;

Varrone, Jeanne ;

Yusuf, Salim .

CIRCULATION, 2011, 123 (21) :2363-U72

[9] Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development [J].

Eriksson, Bengt I. ;

Quinla, Datfiel J. ;

Weitz, Jeffrey I. .

CLINICAL PHARMACOKINETICS, 2009, 48 (01) :1-22

[10] Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment [J].

Fox, Keith A. A. ;

Piccini, Jonathan P. ;

Wojdyla, Daniel ;

Becker, Richard C. ;

Halperin, Jonathan L. ;

Nessel, Christopher C. ;

Paolini, John F. ;

Hankey, Graeme J. ;

Mahaffey, Kenneth W. ;

Patel, Manesh R. ;

Singer, Daniel E. ;

Califf, Robert M. .

EUROPEAN HEART JOURNAL, 2011, 32 (19) :2387-2394

← 1 2 3 4 →